Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN)

Affiliation auteurs!!!! Error affiliation !!!!
TitreActivity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN)
Type de publicationJournal Article
Year of Publication2015
AuteursPatsouris A., Septans A.L, Paillard M.J, Pivot X., Soibinet P., Jovenin N., Robert M., Gourmelon C., Korembaum C., Petit T., Martin-babau J., Brunot A., Lefeuvre-Plesse C., Adele M., Bourgeois H., Som M., Uwer L., Campone M., Campion L., Tredan O.
JournalEUROPEAN JOURNAL OF CANCER
Volume51
PaginationS287
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0959-8049
DOI10.1016/S0959-8049(16)30815-2